Clinical Framework

Why a New Framework Is Needed

Current neurosurgical follow-up excels at detecting structural complications but systematically misses functional and emotional ones. Research estimates that 30–70% of neurosurgery patients experience significant emotional or personality changes, yet 40–60% of these go undetected by standard screening protocols.

The gap is not one of intent but of instrumentation. Standard tools like the PHQ-9 and GAD-7 were designed to detect major depressive disorder and generalized anxiety disorder — clinical entities with defined symptom clusters. The emotional changes after neurosurgery often fall outside these clusters entirely. A patient experiencing identity disruption, emotional blunting, or grief for a former self may score normally on both instruments while suffering profoundly.

The clinical literature documents three categories of change that standard screening consistently misses: personality and behavioral changes that emerge gradually over weeks to months, identity disruption and existential distress that do not map to psychiatric diagnoses, and caregiver burden that compounds the patient's emotional trajectory.

The Three-Dimensional Model

The framework proposes that emotional recovery after neurosurgery unfolds across three interdependent dimensions. Each dimension has distinct clinical presentations, different time courses, and different intervention targets. Effective recovery support requires addressing all three.

Dimension 1: Neurobiological (Body)

The neurobiological dimension encompasses the direct and indirect effects of surgery on neural circuits that regulate emotion, cognition, and behavior. This includes the tissue-level consequences of the procedure itself — edema, retraction injury, vascular disruption, and neuroinflammation — as well as the downstream effects on neurotransmitter systems and neural networks.

Clinical presentations: Cognitive fatigue, processing speed reduction, emotional lability, irritability, sleep architecture disruption, appetite changes, and sensory sensitivity. These changes often emerge in the acute phase but can persist for months to years depending on lesion location, surgical approach, and individual neuroplastic capacity.

Key medication-emotion intersections: Dexamethasone is responsible for a disproportionate share of emotional chaos in the first weeks — mood swings, insomnia, agitation. The taper period deserves explicit preparation. Levetiracetam causes irritability severe enough to damage relationships in a meaningful subset of patients. Distinguishing medication effects from surgical effects is one of the most impactful clinical moves available.

Interventions with evidence: Sleep protection and optimization (Tier 1), structured physical activity (Tier 1), omega-3 supplementation (Tier 1–2), vagal nerve stimulation and HRV biofeedback (Tier 2), and repetitive TMS for post-surgical depression (Tier 1 for depression generally, Tier 2 for post-surgical populations specifically).

Dimension 2: Psychological (Soul)

The psychological dimension addresses the cognitive and emotional processing of neurological change. Patients must integrate a new relationship with their own minds — understanding why they react differently, why familiar tasks feel foreign, and why emotions seem to operate by different rules than before surgery.

Clinical presentations: Anxiety about cognitive decline, grief for lost capabilities, frustration with recovery pace, social withdrawal, relationship strain, fear of recurrence, and the distinctive experience of “not feeling like myself.” These presentations often intensify in the subacute phase (months 1–6) as the initial relief of surviving surgery gives way to the reality of changed function.

What standard screening misses: The PHQ-9 asks about depressed mood and loss of interest. It does not ask “Do you feel like a different person?” or “Are your emotional reactions unfamiliar to you?” A patient can score below clinical threshold on depression and anxiety measures while experiencing profound psychological distress that falls between diagnostic categories.

Interventions with evidence: Cognitive behavioral therapy adapted for neurological populations (Tier 1), acceptance and commitment therapy (Tier 2), neuropsychological rehabilitation (Tier 1 for targeted cognitive domains), and structured psychoeducation about expected changes (Tier 2 but functionally essential).

Dimension 3: Existential (Spirit)

The existential dimension encompasses the meaning-making challenges that emerge when brain surgery alters the felt sense of self. This dimension is least recognized in clinical practice and most consistently reported by patients. It includes questions of identity, purpose, continuity of self, and the relationship between brain and personhood.

Clinical presentations: Identity disruption (“I don't know who I am anymore”), existential grief, loss of sense of future, spiritual or philosophical questioning, difficulty with narrative coherence (the patient's life story no longer flows continuously), and in some cases, paradoxical growth — patients who report that the experience, while devastating, ultimately deepened their relationship with life.

Why this dimension matters clinically: Patients who experience identity disruption without a framework for understanding it often interpret their experience through psychiatric categories (“I must be depressed”) or catastrophic narratives (“The surgery broke me”). Neither interpretation is accurate, and both impede recovery. Providing language for the existential dimension — even briefly, even in a fifteen-minute visit — changes the trajectory.

Interventions with evidence: Meaning-centered therapy (Tier 2), narrative reconstruction approaches (Tier 2–3), existential psychotherapy frameworks (Tier 2), and structured journaling for identity integration (Tier 3 but widely used in related populations). Emerging evidence from deep brain stimulation research provides neurobiological grounding for identity disruption — patients with DBS electrodes have described changes to their sense of self that parallel what neurosurgery patients report.

How the Dimensions Interact

The three dimensions are not independent silos. A patient with unresolved neuroinflammation (neurobiological) may present with emotional lability that strains their marriage (psychological), which in turn triggers existential questioning about who they are becoming (existential). Treating only the neurobiological component — even successfully — will not resolve the psychological and existential layers that have developed.

Conversely, a patient who has developed a coherent narrative about their experience (existential) and has adequate social support (psychological) may tolerate neurobiological symptoms with significantly less distress than a patient with identical neurological findings but no framework for understanding them.

This interaction effect is why the framework advocates assessment across all three dimensions rather than sequential management. A brief check across all three dimensions in a follow-up visit takes less time than investigating a single dimension thoroughly — and is more likely to identify the dimension that is actually driving the patient's distress.